The Ensign Group (NASDAQ:ENSG) PT Lowered to $95.00 at Royal Bank of Canada

Posted by ABMN Staff on Aug 6th, 2022

The Ensign Group (NASDAQ:ENSG – Get Rating) had its target price trimmed by Royal Bank of Canada from $101.00 to $95.00 in a research note released on Wednesday, Benzinga reports. The firm currently has an outperform rating on the stock.

Separately, Truist Financial upped their target price on The Ensign Group from $85.00 to $95.00 in a research report on Wednesday.

The Ensign Group Stock Up 1.2 %

NASDAQ ENSG opened at $84.87 on Wednesday. The stock has a market cap of $4.69 billion, a PE ratio of 23.64, a P/E/G ratio of 1.50 and a beta of 1.03. The Ensign Group has a fifty-two week low of $68.29 and a fifty-two week high of $94.25. The business has a 50 day moving average price of $76.92 and a two-hundred day moving average price of $79.98. The company has a quick ratio of 1.23, a current ratio of 1.28 and a debt-to-equity ratio of 0.13.

The Ensign Group (NASDAQ:ENSG – Get Rating) last announced its earnings results on Monday, August 1st. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.01. The Ensign Group had a return on equity of 19.51% and a net margin of 7.27%. The company had revenue of $732.49 million for the quarter, compared to analyst estimates of $729.44 million. During the same period in the prior year, the company posted $0.83 EPS. The Ensign Group’s quarterly revenue was up 14.7% on a year-over-year basis. As a group, sell-side analysts predict that The Ensign Group will post 3.82 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 29th. Shareholders of record on Thursday, June 30th were given a $0.055 dividend. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date was Wednesday, June 29th. The Ensign Group’s payout ratio is 6.13%.

Insider Activity at The Ensign Group

In related news, CFO Suzanne D. Snapper sold 5,883 shares of the company’s stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $85.16, for a total transaction of $500,996.28. Following the sale, the chief financial officer now directly owns 208,810 shares of the company’s stock, valued at approximately $17,782,259.60. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 4.70% of the company’s stock.

Institutional Investors Weigh In On The Ensign Group

Institutional investors and hedge funds have recently made changes to their positions in the company. D. E. Shaw & Co. Inc. raised its position in shares of The Ensign Group by 238.2% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 140,530 shares of the company’s stock valued at $11,799,000 after acquiring an additional 98,983 shares in the last quarter. CIBC Asset Management Inc acquired a new stake in The Ensign Group in the fourth quarter worth $343,000. Inspire Investing LLC acquired a new stake in The Ensign Group in the first quarter worth $236,000. NorthCrest Asset Manangement LLC acquired a new stake in The Ensign Group in the fourth quarter worth $878,000. Finally, Boston Trust Walden Corp increased its position in The Ensign Group by 4.1% in the first quarter. Boston Trust Walden Corp now owns 292,394 shares of the company’s stock worth $26,319,000 after buying an additional 11,427 shares during the period. 88.03% of the stock is owned by institutional investors and hedge funds.

The Ensign Group Company Profile

(Get Rating)

The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services.